Tag: Apnimed

All

Apnimed’s Sleep Apnea Drug Candidate Improves Daytime Impairment, In Addition to Lowering AHI

Apnimed announced positive topline results from the MARIPOSA Phase 2b trial, a study of its lead drug candidate for obstructive sleep apnea.

FDA Grants Fast Track Designation to Apnimed Sleep Apnea Drug Candidate AD109
Apnimed’s Second Core Sleep Apnea Drug Candidate, AD504, Lowers AHI
How Close Are We to Drug Therapy for Obstructive Sleep Apnea?
Apnimed Raises $62.5M to Advance Lead Sleep Apnea Pill Candidate to Phase 3
Proof-of-Concept Crossover Study of Two Sleep Apnea Pill Candidates Shows Promising Results
Study Looks at Oral Pharmacologic OSA Treatments

All

New Studies: Sleep Apnea Pill Shows Durability of Effect & Improved Quality of Life in Mild to Severe OSA

The randomized, placebo-controlled segment of the study showed that AD109 had a statistically significant and clinically meaningful difference from placebo after a single dose in the patients’ hypoxic burden.

Sleep Specialist Becomes SVP, Medical Affairs at Sleep Apnea Pill Development Company Apnimed
Sleep Apnea Pill Data Presented at ATS 2021: ‘These Data Reinforce the Potential of Pharmacotherapy in Treating OSA’
Sleep Apnea Pill Earns $25 Million in Financing for Continued Development & Commercialization
First Patient Dosed in Sleep Apnea Pill Second Phase 2 Clinical Trial
First Patient Dosed in Sleep Apnea Pill Phase 2 Clinical Trial
Investigational Sleep Apnea Drug to Move to Phase 2 Trial
Treating Sleep Apnea with Pills Instead of Machines

Tag: Apnimed

All

Apnimed’s Sleep Apnea Drug Candidate Improves Daytime Impairment, In Addition to Lowering AHI

FDA Grants Fast Track Designation to Apnimed Sleep Apnea Drug Candidate AD109

Apnimed’s Second Core Sleep Apnea Drug Candidate, AD504, Lowers AHI

How Close Are We to Drug Therapy for Obstructive Sleep Apnea?

Apnimed Raises $62.5M to Advance Lead Sleep Apnea Pill Candidate to Phase 3

Proof-of-Concept Crossover Study of Two Sleep Apnea Pill Candidates Shows Promising Results

Study Looks at Oral Pharmacologic OSA Treatments

All

New Studies: Sleep Apnea Pill Shows Durability of Effect & Improved Quality of Life in Mild to Severe OSA

Sleep Specialist Becomes SVP, Medical Affairs at Sleep Apnea Pill Development Company Apnimed

Sleep Apnea Pill Data Presented at ATS 2021: ‘These Data Reinforce the Potential of Pharmacotherapy in Treating OSA’

Sleep Apnea Pill Earns $25 Million in Financing for Continued Development & Commercialization

First Patient Dosed in Sleep Apnea Pill Second Phase 2 Clinical Trial

First Patient Dosed in Sleep Apnea Pill Phase 2 Clinical Trial

Investigational Sleep Apnea Drug to Move to Phase 2 Trial

Treating Sleep Apnea with Pills Instead of Machines

All

Sorry, No Posts Found

Sorry, No Posts Found